<SUBMISSION>
<SECRELEASE-DATETIME> 20200129-060723 ⇐ Metadata from SEC Info (ET)
<SECWEBSITE-DATETIME> 20200129-060723 ⇐ Metadata from SEC Info (ET)
<ACCEPTANCE-DATETIME> 20200129-060603 ⇐ Filing accepted by SEC (ET)
<ACCESSION-NUMBER> 0001104659-20-007806
<TYPE> S-1MEF
<PUBLIC-DOCUMENT-COUNT> 4
<REFERENCE-462B> 333-232529
<FILING-DATE> 20200129
<DATE-OF-FILING-DATE-CHANGE> 20200129
<EFFECTIVENESS-DATE> 20200129
|
<FILER>
<COMPANY-DATA>
<CONFORMED-NAME> Annovis Bio, Inc.
<CIK> 0001477845
<ASSIGNED-SIC> 2834
<IRS-NUMBER> 262540421 ⇒ 26-2540421 or 262-54-0421
<STATE-OF-INCORPORATION> DE
<FISCAL-YEAR-END> 1231
</COMPANY-DATA>
<FILING-VALUES>
<FORM-TYPE> S-1MEF
<ACT> 33
<FILE-NUMBER> 333-236126
<FILM-NUMBER> 20556266
</FILING-VALUES>
<BUSINESS-ADDRESS>
<STREET1> 1055 WESTLAKES DRIVE, SUITE 300
<CITY> BERWYN
<STATE> PA
<ZIP> 19312
<PHONE> 610-727-3913
</BUSINESS-ADDRESS>
<MAIL-ADDRESS>
<STREET1> 1055 WESTLAKES DRIVE, SUITE 300
<CITY> BERWYN
<STATE> PA
<ZIP> 19312
</MAIL-ADDRESS>
<FORMER-COMPANY>
<FORMER-CONFORMED-NAME> QR Pharma, Inc.
<DATE-CHANGED> 20091202
</FORMER-COMPANY>
</FILER>
|
<DOCUMENT>
<TYPE> S-1MEF
<SEQUENCE> 1
<FILENAME> a19-9635_14s1mef.htm
<DESCRIPTION> S-1MEF
<TEXT>
<html>
Show <HTML>: 555 lines (widest: 864 characters) - 66K bytes
</TEXT>
</DOCUMENT>
|
<DOCUMENT>
<TYPE> EX-5.1
<SEQUENCE> 2
<FILENAME> a19-9635_14ex5d1.htm
<DESCRIPTION> EX-5.1
<TEXT>
<html>
Show <HTML>: 101 lines (widest: 1,183 characters) - 16K bytes
</TEXT>
</DOCUMENT>
|
<DOCUMENT>
<TYPE> EX-23.1
<SEQUENCE> 3
<FILENAME> a19-9635_14ex23d1.htm
<DESCRIPTION> EX-23.1
<TEXT>
<html>
Show <HTML>: 37 lines (widest: 887 characters) - 4K bytes
</TEXT>
</DOCUMENT>
|
<DOCUMENT>
<TYPE> GRAPHIC
<SEQUENCE> 4 ⇐ Not a Document/Exhibit
<FILENAME> g963513kii001.jpg
<DESCRIPTION> GRAPHIC
<TEXT>
Show <TEXT>: 59 lines (Unix-to-Unix encoding) - 4K bytes
</TEXT>
</DOCUMENT>
|
</SUBMISSION> |
↑Top |